Bulletin

Examine access policies and pathways for innovative medicines in China. We closely monitor the latest developments in these areas and provide concise updates, along with our take, delivered to your inbox every Wednesday.

Apr

Key Direction for Huiminbao Drug Formulary at China's National Two Sessions

During China's 2024 National Two Sessions in March, Wu Fan, a member of the National Committee of the

Apr 3, 2024

2 min read

Mar

Pudong Drug Pricing Pilot

#1 Pudong reform pilot permits new drug launch pricing comparable to international markets. On January 22nd, a joint announcement was

Mar 27, 2024

3 min read